Boehringer held up by FDA for production violations
May 24, 2013Manufacturing and Production API, Boehringer, FDA
Boehringer Ingelheim has pledged to resolve manufacturing compliance issues at a facility in Germany uncovered by the US Food and …
GSK to cull Australian tablet packaging plant
May 23, 2013Manufacturing and Production Australia, GSK
A GlaxoSmithKline tablet packaging facility in Australia will be closed with the loss of 120 jobs, around a third of …
Positive news for Sanofi asthma drug
May 23, 2013Sales and Marketing Dupilumab, Regeneron, Sanofi, asthma
An asthma drug being developed by Sanofi and Regeneron Pharmaceuticals has performed well in a Phase IIa trial, reducing the …
Nicholson to step down as NHS leader
May 23, 2013Sales and Marketing Francis report, Mid Staffs, NHS, Nicholson
Sir David Nicholson is to retire from his post as chief executive of NHS England in March 2014.Sir David has …
GSK gets $200m from White House
May 23, 2013Research and Development, Sales and Marketing AMR, BARDA, GSK, HHS, white house
GlaxoSmithKline is to be given up to $200 million by the US government to develop new antibiotics as worries grow …
Bayer hires chief information officer
May 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, information
Johannes Schubmehl has been appointed chief information officer of Bayer HealthCare. Schubmehl succeeded Matthias Moritz, who left the company at …
Actavis snaps up Warner Chilcott
May 22, 2013Research and Development, Sales and Marketing Actavis, Warner Chilcott
Actavis is to buy Dublin-based firm Warner Chilcott in an $8.5 billion deal which will see the Warner name disappear …
ABPI takes on vaccine industry brief
May 22, 2013Research and Development ABPI, vaccines
The ABPI is to take on responsibility for representing the vaccine industry to UK government and healthcare stakeholders.For more than …
Pfizer abandons cancer trial
May 22, 2013Research and Development, Sales and Marketing Cancer, Inotuzumab ozogamicin, Pfizer, oncology
Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …
Board changes at Boehringer Ingelheim
May 22, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, baiker
Boehringer’s Professor Wolfram Carius is stepping down from the Board to be replaced by Dr Wolfgang Baiker. Carius who is …
Bayer to buy Steigerwald
May 21, 2013Sales and Marketing Bayer, steigerwald
Bayer is to buy herbal medicines specialist Steigerwald Arzneimittelwerk in a deal which it says is motivated in part by …
AndersonBrecon joins fast-growing contract packer PCI
May 21, 2013Manufacturing and Production AndersonBrecon, PCI
Pharma packaging and clinical trial services company AndersonBrecon has been bought by a US private equity group in a £200 …
Canada tightens GMP rules for active ingredients
May 21, 2013Manufacturing and Production API, Canada, GMP
Canada’s Food and Drug Regulations have been amended to extend the requirements for Good Manufacturing Practices (GMP) to active pharmaceutical …
New general manager for Eisai in Mexico
May 21, 2013Manufacturing and Production, Research and Development, Sales and Marketing
Eisai has appointed Ricardo Gonzalez Balboa to the position of general manager, Eisai Mexico. In this position, Gonzalez Balboa will …
New fund for electronic prescribing
May 21, 2013Sales and Marketing Francis report, IT, NHS, electronic prescribing
A new £260 million fund is to help accelerate progress toward electronic prescribing in NHS hospitals.The government says it is …
AbbVie and Galapagos extend deal
May 21, 2013Sales and Marketing AbbVie, Crohn's, Galapagos
AbbVie and Belgian biotech Galapagos have bolted on a development programme for Crohn’s disease to the selective JAK1 inhibitor they …
Working with the NHS in austerity
May 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, atkin, austerity, reforms, wellards
The National Health Service, perhaps the UK’s most deeply loved institution, is facing a double threat. On one hand, there …
Promise for Lundbeck and Takeda’s depression drug
May 20, 2013Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly
Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …
Biotec Services expands presence in Israel
May 20, 2013Research and Development, Sales and Marketing Biotec
Clinical supplies firm Biotec Services International has expanded its presence in Israel with the appointment of a new Israeli agent. …
Excipient certification scheme launches in US
May 17, 2013Manufacturing and Production EXCiPACT, GMP
A certification scheme for pharmaceutical excipients to make it easier for drugmakers to source materials from reliable suppliers made its …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
